Moreover, CBD decreased Aβ levels in SH-SY5Y cells transfected with the amyloid precursor protein (SH-SY5YAPP+) [64], and, in an Alzheimer’s disease mouse model, CBD administration ameliorated cognitive impairment [112]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.